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Reactions of laser-desorbed Na+, Kf, Rb+, and Cs+ with thermally vaporized valinomycin 
generate metal-ligand complexes in a Fourier transform ion cyclotron resonance trapping 
cell, proving that complexes can form via gas-phase ion-molecule reactions. Although 
desorption of intact pre-formed complexes cannot be ruled out, this route appears minor. 
Relative rate constants for the complexation reactions show strong dependence on the charge 
densities of the cations. Competition experiments between valinomycin and the synthetic 
ionophores 18.crown-6 (18C6) and [2.2.2]-cryptand Q2.2.21) show that valinomycin has a 
higher intrinsic alkali metal cation affinity than either 18C6 or [2.2.2], in contrast to the 
complex formation constants observed in methanol, where Kt affinities are in the order 
l2.2.21 > 18C6 > valinomycin. (1 Am Six Muss Spectrom 1994, 5, 632-637) 
W ith the development of new ionization tech- niques such as matrix-assisted laser desorp- tion [l] and elcctrospray [2], the role of mass 
spectrometry in biological research has profoundly ex- 
panded. Because both methods often produce alkali 
metal-attached molecular ions, the process of alkali 
cation attachment has also taken on new importance. 
Additionally, alkali cations such as Li+, Na+, and K+ 
have been shown to be very useful chemical ionization 
reagents [3-51. A clear understanding of what factors 
govern cation binding strengths and binding site pref- 
erences is crucial for obtaining structural information 
from the mass spectra of large cationized molecules. 
Until recently, most studies of alkali cation attach- 
ment have focused on binding to bases with only one 
donor site. However, for large molecules such as pep- 
tides, it is likely that multidentate attachment, through 
several interacting donor groups, is more important 
[4,5]. In ligands capable of multidentate binding, bind- 
ing strengths can be very different from those expected 
based on comparison with unidentate ligands [3,6]. 
Hence, it is important to understand multidentate liga- 
tion in the gas phase. 
We [7-101 and others [ll-151 have used crown 
ethers as model compounds for the investigation of 
multidentate alkali cation binding in the gas phase. 
These ionophoric ligands, which show remarkable 
cation binding selectivity in solution, exhibit equally 
interesting gas-phase chemistry. For example, size rela- 
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tionships between the cations and the cavities of the 
ligands can strongly influence both the kinetics and 
thermodynamics of the binding interactions [7-9,141. 
In this paper we report some initial attempts to extend 
our studies to include larger naturally occurring 
ionophores, such as valinomycin, which are of greater 
analytical and biological interest than the simple syn- 
thetic ligands we have examined heretofore. Valino- 
mycin is a good choice for this extension because it is 
similar to the crown ethers in cation binding function 
and because it is well studied in solution, offering the 
possibility of gas-phase comparison studies for under- 
standing solvation effects. 
Valinomycin is a cyclic depsipeptide, built from a 
threefold repetition of the alternating amino acid and 
hydroxy acid residues L-valine, n-cY-hydroxyvaleric 
acid, D-V&W, and L-lactic acid. It functions as an 
antibiotic by influencing cation transport across cell 
membranes. Binding constants measured in methanol 
indicate valinomycin selectively binds Rbf in prefer- 
ence to the other alkali metal ions [16,17]. Its sclectiv- 
ity for K+ over Na+ is especially well established [18]. 
It has been proposed that the selectivity of valino- 
mycin for K+ over Na* correlates with the size of the 
binding cavity formed by the cyclic ionophore [19]. 
Theoretical studies have shown that the selectivity 
displayed by valinomycin with respect to the binding 
of alkali metal cations is a result of a trade-off between 
the interaction energies of this macrocyclic carrier with 
the alkali metal cations and the corresponding hydra- 
tion energies of the cations and the l&and [20,X]. 
Gas-phase experiments are important because they di- 
rectly probe the intrinsic selectivity of the l&and, in 
the absence of interfering solvation effects. 
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A number of gas-phase studies involving iialino- 
mycin have appeared. A cross section for proton trans- 
fer from protonated valiiomycin to ammonia of 2.4 f 
1.2 X lo-l7 cm2 molecule-l, at a collision energy of 
26.5 eV in the center-of-mass frame, has been mea- 
sured, along with an estimated cross section for colli- 
sion-induced dissociation (CID; with ND, as the neu- 
tral target), of 2.0 X lo-l4 cm2 molecules’ [22]. The 
very small cross section for proton transfer probably 
reflects steric or orientational requirements for the re- 
action 
Thermally vaporized valinomycin has been exam- 
ined by using methane chemical ionization (CI) in a 
Fourier transform ion cyclotron resonance (ICR) instru- 
ment [23]. The [M + HI+ peak at m/z 1111.6 domi- 
nates the mass spectrum under low-pressure CI condi- 
tions. Low energy CID in these experiments yielded a 
number of structurally significant product ions that 
give sequence information. Tandem mass spectrometry 
of fast-atom bombardment (FAB)-generated [M + K]+ 
ions yields Kf ions as the base peak in the spectnun, 
which suggests that loss of K+ is energetically pre- 
ferred over fragmentation of the ligand [24]. 
In this article we report relative rates for the attach- 
ment of alkali cations to valinomycin, which illustrate 
the importance of cation charge density in the com- 
plexation process. In addition, we compare the gas- 
phase alkali cation affinities of valinomycin and com- 
parable synthetic ionophores, 18-crown-6 and [2.2.2]- 
cryptand, and contrast the results with data obtained 
in solution. 
Experimental 
Valinomycin-alkali metal cation complexes were read- 
ily generated and trapped in the gas phase by using 
laser desorption Fourier transform ion cyclotron reso- 
nance mass spectrometry. The solvent used for sample 
preparation in all experiments was absolute methanol. 
Valinomycin was dissolved in methanol, doped with 
an excess of the metal nitrate of interest, and deposited 
onto the tip of a stainless steel sample probe, where 
the solvent was evaporated. The loaded probe was 
inserted through a vacuum lock such that the tip was 
about 10 cm from the end of a capacitively coupled 
open ICR cell [25,26]. Samples were desorbed into the 
gas phase when the probe tip was irradiated with the 
focused output (1 to 5 mJ pulse-‘) from a Lambda 
Physik (Acton, MA) LPX 205i/FL 3002 excimer- 
pumped dye laser (h = 360 nm). Experiments were 
conducted with a modified Millipore/Extrel (Madison, 
WI) FTMS-1000 instrument, equipped with a 3-T su- 
perconducting solenoid magnet, which has been de- 
scribed previously [9,10]. Cell pressures, measured by 
using a Bayard-Alpert ionization gauge mounted ex- 
ternal to the region of strong magnetic field, were 
typically 2 to 8 X lo-’ ton. The mass scale of the 
instrument was calibrated using electron impact (70- 
eV) ionization of tris_(perfluorononyl2s-triazine, Which 
yields several suitable calibration peaks in the 970 to 
1485 mass-to-charge ratio range. Medium resolution 
spectra (m/Am of 3000 to 4000) were typically ob- 
tained with 64K data points and a bandwidth of 127 
kHz in heterodyne mode. 
Spectra were obtained for complexes with Na+, K+, 
Rb+, and Cs+ with sufficient resolution to resolve the 
13C isotope peaks. Both resolution and signal-to-noise 
ratio were improved by operating at low trapping 
voltages (0.02 to 0.2 V). This is probably due to re 
duced space charge effects at low trapping potential. 
Laser desorption produces ions with a wide range of 
kinetic energies [27]. Low trapping potentials allow 
ions with large energies in the z-direction (along the 
magnetic field lines) to escape, retaining only ions with 
small kinetic energy in the z-direction. The low trap- 
ping potential therefore lowers the ion density in the 
trap and selects a more uniform distribution of kinetic 
energies. Both factors probably assist in ion detection 
[28]. Operation at low trapping voltage is probably 
more difficult in a closed cell: axial ejection of ions 
during excitation [29-311 in a conventional cubic cell 
can be quite severe at low trapping potential. 
The relative intensities of the peaks matched well 
with the expected isotope distributions of the valino- 
my&-metal complexes. The observation of peaks at 
the expected mass-to-charge ratio values, along with 
the expected isotopic patterns, confirms the mass 
spectroscopic assignments. The error in mass-to-charge 
ratio is about +0.05%, which is rather large for a 
Fourier transform mass spectrometry mass determina- 
tion. Mass scale calibration was done at a trapping 
potential of 1.0 V, whereas the spectra were acquired 
at much lower trapping voltages (0.02 to 0.2 V). The 
positive shift in mass-to-charge ratio with decreased 
trapping potential is contrary to expectations from 
theory [32]. Possibly the deviation is due to magnetic 
capacitors that were attached to the cell during the 
experiment. It is also possible that at very low trapping 
potentials the local electrostatic field in the vicinity of 
the ions, which leads to shifts in effective cyclotron 
frequency, is dominated by space charge rather than 
by the applied trapping field. If so, quantitative predic- 
tions about shifts in effective cyclotron frequency could 
not be made without detailed knowledge of the space 
charge effects. 
In experiments designed to determine whether com- 
plexes were desorbed intact or formed in gas-phase 
ion-molecule reactions, the alkali metal nitrate was 
laser desorbed from the probe surface and valinomycin 
was introduced separately by thermal vaporization of 
a sample placed in a small capillary tube mounted in 
the center of the temperature-controlled probe. Tem- 
peratures of about 300 “C (measured with a thermo- 
couple in the probe tip) were required. By using the 
same technique, the relative rates of metal complexa- 
tion were investigated. In these experiments, two or 
more alkali metal nitrates were co-deposited on the 
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probe and desorbed together, ensuring that each cation 
is exposed to the same pressure conditions in the cell. 
The intensities of the metal ion peaks, as well as those 
of the complex peaks, were followed as a function of 
time and analyzed assuming pseudo-first-order kinetic 
conditions. Corrections were made for metal ion losses 
arising from attachment to neutral species other than 
valinomycin, which were also present in the chamber. 
Because we were unable to measure absolute valino- 
mycin partial pressures, only relative rate constants 
were obtained. 
Relative complex stabilities were examined in com- 
petition experiments between valinomycin (Vm) and 
the synthetic ionophores N-crown-6 (18C6; Sigma 
Chemical Co., St. Louis, MO) and [2.2.2]-cryptand 
([2.2.2]; Aldrich Chemical Co., Milwaukee, WI). Reac- 
tions (1) and (2) were each examined in both directions 
and ionic reactants were isolated by using standard 
Fourier transform ICR swept-rf methods [32], and 
products were monitored as a function of time: 
Vm + [2.2.2]M++ VmM++[2.2.2] (1) 
Vm + 18C6M++ VmM++ 18C6 (2) 
Discussion 
The structures of valinomycin, 18-crownd, and 
[2.2.2]-cryptand are shown in Figure 1. Although we 
cannot rule out desorption of intact pre-formed metal 
complexes from mixtures of the ligand with metal 
salts, it is clear that the complexati& can occur as a 
purely gas-phase reaction. Thermal evaporation of 
valinomycin, accompanied by laser desorption of alkali 
metal salts, resulted in the formation of metal com- 
plexes in the gas phase via ion-molecule reactions. 
Whereas the two reactants in this experiment cannot 
come in contact except in the gas phase, this clearly 
demonstrates that gas-phase complexation is possible. 
The mass spectra include some peaks assigned to vali- 
nomycin fragments. Fragments might arise from par- 
tial thermal decomposition of the ligand at the temper- 
valinomycin 
1 B-crown-6 [2.2.2] 
Figure 1. Structures of the ligands used in this study. 
ature required for evaporation. In addition, it may be 
that the energy released by the complexation reaction 
is sufficient to result in fragmentation. 
The relative complexation rates with respect to 
potassium-complex formation are shown in Table 1. 
The relative rate constants decrease as the mass of the 
cation increases, and seem to correlate with collision 
rates calculated by using ion-induced dipole collision 
theory 1331, which predicts an inverse dependence on 
the square root of the reduced mass of the collision 
pair. A close look at the data suggests, however, that 
the reactions are not collision controlled and that de- 
tails of the metal-ligand interaction are probably im- 
portant in determining relative rates. 
The dipole moment of valinomycin in solution has 
been calculated and ranges up to 6.3 D depending on 
the nature of the solvent system [34]. In a hydrocarbon 
solvent (dioxane-octane), valinomycin has a dipole 
moment of 3.9 D [34]. We expect that valmomycin in 
the gas phase has a dipole moment similar to that in a 
nonpolar solvent. If we assume the complexation reac- 
tion is collision limited and use this dipole moment, 
average dipole orientation (ADO) theory [33] can be 
used to estimate absolute reaction rates and the valino- 
mycin vapor pressure. Table 1 shows collision rates 
(both absolute and relative) estimated from theory. 
The estimated absolute rate constants are on the order 
of 10m9 cm3 molecule-’ s-i. From these data the 
valinomycin vapor pressure is estimated to be approxi- 
mately 10m9 torr, on the same order as the baseline 
pressure of our instrument. 
It is very interesting to note, from the last column of 
Table 1, that the reaction efficiencies decrease as the 
size of the metal cation increases (i.e., the reaction rates 
vary by more than the amount of variation predicted 
for the collision rates). If all the reactions really are 
collision controlled, the data could be explained if 
approaches such as ADO theory are not adequate for 
describing large-molecule systems such as this one. For 
large molecules like valinomycin, the assumption that 
the colliding ion and molecule are point particles (im- 
plicit in polarization theory) may break down. How- 
ever, the collision cross section estimated by using 
Lang&in theory 1331 is about 920 to 960 k, whereas 
the physical cross section of valinomycin estimated 
from x-ray data 1351 is about 77 A*. Even for a molecule 
as large as valinomycin, the Langbvin cross section is 
much larger than the physical extent of the molecule. It 
is unlikely that the size of valinomycin accounts for 
large failures in collision theory. 
A much more likely explanation is that the com- 
plexation reactions are not collision controlled and that 
the decrease in reaction efficiency with increasing 
cation size is real. It seems plausible that the higher 
charge density for the smaller cations may lead to 
greater ion-dipole interactions with the ligand, induc- 
ing more rapid rearrangement of the ligand into a 
conformation favorable for binding. These kinds of 
effects have been postulated to explain similar trends 
in the efficiencies of alkali cation complexation by 
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Table 1. Relative experimental rate con?.tants (normalized to values for K+) and calculated calkim rate constants for the formation 
of valinomycin-alkali metal ion complexes 
Cation 
Na+ 
K+ 
Rb+ 
Csf 
Relative 
rate 
constant 
1.9 It 0.4 
1 
0.31 * 0.03 
0.15 + 0.04 
Estimated Collision Rate Constants 
Absolute 
(x 1 OS cm3 molecule” s.‘) Relative 
6.5 1.3 
5.0 1 
3.5 0.69 
2.8 0.59 
Relative 
reaction 
efficiency 
1.5 + 0.3 
1 
0.45 f 0.04 
0.25 k 0.07 
crown ethers [9]. In fact, we have observed similar 
effects with every ligand we have investigated. 
The transfer of alkali metal cations (Nat, K’, Rb*, 
and Cs’) from two synthetic ionophores ([2.2.2] and 
lBC6) to valinomycin was observed. Figure 2 shows 
the transfer of Kf from the [2.2.2]-cryptate complex to 
valinomycin as a function of reaction time. Both the 
decay of the reactant signal and growth of the product 
signal can be fitted with single exponential functions 
with the same rate constant, consistent with a pseudo- 
first-order reaction. The reverse reactions were not 
seen, even though the neutral vapor pressures of the 
synthetic ionophores were certainly much greater than 
that of valinomycin. The formation of heterogeneous 
211 1igand:metal complexes involving valmomycin also 
was not observed, even at reaction times of several 
minutes. For simple crown ether ligands, this failure to 
observe 2:l 1igand:metal species was interpreted to 
indicate that the metal is effectively encapsulated in 
the 1:l complexes, making it unavailable as a site to 
attach a second ligand [7,9]. For a large ligand such as 
valinomycin, it is not surprising that the cation might 
be enveloped by the neutral host molecule. 
In other cation-ionophore systems where both the 
forward and reverse reactions were observed, equilib- 
rium constants were determined [9]. The variation of 
equilibrium constant with cation size exhibited pat- 
terns that could be rationalized in terms of the selectiv- 
a c,K+ I I 0 VmK+ 
o- 
0 10203040506070 
Time, seconds 
Figure 2. Relative intensities of valinomycin-K+ and [2.2.2]-K’ 
complexes as a function of time, showing transfer of K+ from 
[2.2.2l-cryptate complex to valinomycin. 
ity of the ligands for cations of a particular size. Unfor- 
tunately, failure to observe equilibrium in the valino- 
mycin system precludes a detailed analysis of selective 
cation binding in this system, although on the basis of 
comparison to the functionally similar crown ethers we 
believe it likely that such selectivity exists in the gas 
phase. One approach to quantify the gas-phase selec- 
tivity is to identify other gas-phase ligands with cation 
affinities similar to those of valinomycin so that equi- 
librium constants can be measured. This approach SUC- 
cessfully revealed selectivity patterns in a simple crown 
ether-alkali metal cation system [9]. 
The observation of alkali cation transfer from either 
18C6 or [2.2.2] to valinomycin and failure to observe 
transfer from valinomycin to a large excess of either 
ligand indicates that valinomycin-alkali metal com- 
plexes are more stable than the [2.2.2]-cryptate and 
18C6 metal complexes in the gas phase. This is in 
direct contrast to the complexation properties observed 
in solution. For example, in methanol the stability 
constants for [2.2.2] complexes of Nat, K’, Rb+, and 
Cs+ average 4.0 log K units greater than the corre- 
sponding constants for valiiomycin complexes. The 
same comparison in acetonitrile yields an average 
difference of 3.41og K units stronger for the cryptates 
m. 
We can speculate on the reasons for these striking 
differences. Factors such as differences in the number 
and type of donor groups in valinomycin versus the 
synthetic ligands probably cannot account easily for 
the differences, because these factors are also present 
in solution. Solvation can have dramatic effects on 
structure, which might explain the differences in solu- 
tion and gas-phase behavior. Based on studies in vari- 
ous solvents, the conformation of valinomycin is highly 
solvent-dependent [34,35]. In nonpolar solvents (e.g., 
Ccl,), all six of the amide hydrogens of valinomycin 
form 14 type intramolecular hydrogen bonds to the 
amide carbonyl oxygens [34,35]. In polar solvents (e.g., 
methanol), valinomycin adopts an open conformation 
with no intramolecular hydrogen bonds. Instead, hy- 
drogen bonds to solvent molecules are formed [34,35]. 
The solvent molecules may be considered as compet- 
ing with metal ions for the binding site(s). As a result, 
complex formation is destabilized in polar solvents. 
This is illustrated for K+ complexes by stability con- 
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stants measured in dioxaneewater mixtures. As the 
dioxane fraction of the solvent increases, the stability 
constants increase dramatically [36]. 
In the gas phase the destabilizing influence of the 
solvent is not present. Preorganization of valinomycm 
due to intramolecular hydrogen bonding would there- 
fore be expected. Both MC6 and [2.2.2] lack hydrogen 
bond donors that could lead to this type of preorgani- 
zation, so the absence of solvent should not affect the 
stability of their complexes to as large an extent. It is 
also likely that valinomycin has a higher solvation 
energy than either of the synthetic ionophores. To the 
extent that complexation requires desolvation of the 
ligand, valinomycin would experience a greater disad- 
vantage in solution than the smaller less-solvated syn- 
thetic ligands. This disadvantage is also absent in gas- 
phase complexation, leading to a relative increase in 
the cation affinity of valinomycin in the gas phase. 
Low cation lability in the valiiomycin complexes 
may also account for the failure of cations to transfer to 
the synthetic ligands, in which case the apparent sta- 
bility differences might be kinetic artifacts. In the solid 
state, the conformations of the complexes are stabilized 
by six intramolecular hydrogen bonds [37,38]. The 
conformation of the gas-phase complex may also be 
reinforced by intramolecular hydrogen bonds that 
cause the structure to become very rigid, hence “lock- 
ing” the central cation tightly. Alternatively, the metal 
ions may be “buried” deep inside the large @and, 
making them inaccessible for transfer to a second lig- 
and. This is quite similar to the behavior of crown 
ether-alkali metal cation complexes in which small 
metal ions, buried in the cavity of a crown ether 
molecule, do not readily bind a second ligand [7,9]. 
Self-exchange experiments with isotopically labeled 
ligands should shed light on this question. Preliminary 
experiments with crown ethers indicate that even met- 
als such as Lit, which are quite tightly bound, are also 
very labile, suggesting that the high cation affinity is 
not a kinetic artifact. We are now beginning such 
studies with larger ligands like valinomycin. 
Finally, if the metal-ligand interactions are primar- 
ily electrostatic in nature and therefore dominated by 
the polarizability of the l&and, it is not surprising that 
valinomycin should have relatively high alkali metal 
cation affinities. Crown ether-alkali metal cation com- 
plexes in the gas phase appear to be highly sensitive to 
these kinds of effects [9]. The polarizabilities of valino- 
mycin, 18C6, and [2.2.2] are 112.8, 25.9, and 39.0 A3, 
respectively, calculated via the method of atomic hy- 
brid components [39,40]. The polarizabilities of these 
three ligands follow the same order as the observed 
gas-phase alkali cation affinities. The ion-induced 
dipole interaction should be stronger in valinomycin 
cation complexes than in complexes involving 18C6 or 
[2.2.2], and may also lead to the greater stability of 
valinomycin-metal ion complexes. 
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Conclusion 
Cation attachment to valmomycin is a rapid gas-phase 
process, with small, charge-dense cations such as Na+ 
reacting more efficiently than large, diffuse cations 
such as Cs’. The relationship between high cation 
charge density and complexation efficiency appears to 
be general; it is evident in every system we have 
examined. Valinomycin has much higher intrinsic 
affinity for the alkali metal cations than smaller syn- 
thetic analogs such as MC6 or [2.2.2]. In fact, valino- 
mycin has the highest alkali cation affinities we have 
yet observed. It will be interesting and challenging to 
identify ligands with alkali cation affinities similar to 
those of valinomycm, in the hope that such ligands can 
be used to probe the selectivity of valinomycin toward 
these cations in the gas phase. As a reviewer suggests, 
experiments with other large cyclic peptides such as 
gramicidin S might provide very useful comparisons 
that could shed light on why the alkali cation affinity 
of valinomycin is so large and whether cation affinities 
increase with ligand size and polarizability in general. 
Finally, solvation disfavors complexation by valino- 
mycin relative to that by the synthetic ligands, again 
underscoring how trends observed in solution do not 
necessarily extrapolate to the simpler gas-phase envi- 
ronment. 
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